Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 29 September 1995:
Vol. 269. no. 5232, pp. 1835 - 1842
DOI: 10.1126/science.7569920
Prev | Table of Contents | Next

Articles

Science, Vol 269, Issue 5232, 1835-1842
Copyright © 1995 by American Association for the Advancement of Science

articles

From molecular diversity to catalysis: lessons from the immune system

PG Schultz and RA Lerner

Howard Hughes Medical Institute, Department of Chemistry, University of California, Berkeley 94720, USA.

By combining the enormous molecular diversity of the immune system with basic mechanistic principles of chemistry, one can produce catalytic antibodies that allow control of reactions in ways heretofore not possible. Mechanistic and structural studies of these antibodies are also providing insights into important aspects of enzymatic catalysis and the evolution of catalytic function. Moreover, the ability to rationally direct the immune response to generate selective catalysts for reactions ranging from pericyclic and redox reactions to cationic rearrangement reactions underscores the chemical potential of this and other large combinatorial libraries.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Human Germ Line Antibody Light Chain with Hydrolytic Properties Associated with Multimerization Status.
V. Sharma, W. Heriot, K. Trisler, and V. Smider (2009)
J. Biol. Chem. 284, 33079-33087
   Abstract »    Full Text »    PDF »
Conformational Isomerism Can Limit Antibody Catalysis.
E. W. Debler, R. Muller, D. Hilvert, and I. A. Wilson (2008)
J. Biol. Chem. 283, 16554-16560
   Abstract »    Full Text »    PDF »
A Metalloantibody That Irreversibly Binds a Protein Antigen.
K. Trisler, L. L. Looger, V. Sharma, M. Baker, D. E. Benson, S. Trauger, P. G. Schultz, and V. V. Smider (2007)
J. Biol. Chem. 282, 26344-26353
   Abstract »    Full Text »    PDF »
Structural Basis for D-Amino Acid Transamination by the Pyridoxal 5'-Phosphate-dependent Catalytic Antibody 15A9.
B. Golinelli-Pimpaneau, C. Luthi, and P. Christen (2006)
J. Biol. Chem. 281, 23969-23977
   Abstract »    Full Text »    PDF »
Specific HIV gp120-cleaving Antibodies Induced by Covalently Reactive Analog of gp120.
S. Paul, S. Planque, Y.-X. Zhou, H. Taguchi, G. Bhatia, S. Karle, C. Hanson, and Y. Nishiyama (2003)
J. Biol. Chem. 278, 20429-20435
   Abstract »    Full Text »    PDF »
Broadly Distributed Chemical Reactivity of Natural Antibodies Expressed in Coordination with Specific Antigen Binding Activity.
S. Planque, H. Taguchi, G. Burr, G. Bhatia, S. Karle, Y.-X. Zhou, Y. Nishiyama, and S. Paul (2003)
J. Biol. Chem. 278, 20436-20443
   Abstract »    Full Text »    PDF »
Structure-based Rational Design of Streptavidin Mutants with Pseudo-catalytic Activity.
Y. Pazy, B. Raboy, M. Matto, E. A. Bayer, M. Wilchek, and O. Livnah (2003)
J. Biol. Chem. 278, 7131-7134
   Abstract »    Full Text »    PDF »
From the Cover: Chemical complementation: A reaction-independent genetic assay for enzyme catalysis.
K. Baker, C. Bleczinski, H. Lin, G. Salazar-Jimenez, D. Sengupta, S. Krane, and V. W. Cornish (2002)
PNAS 99, 16537-16542
   Abstract »    Full Text »    PDF »
A structural basis for the activity of retro-Diels-Alder catalytic antibodies: Evidence for a catalytic aromatic residue.
M. Hugot, N. Bensel, M. Vogel, M. T. Reymond, B. Stadler, J.-L. Reymond, and U. Baumann (2002)
PNAS 99, 9674-9678
   Abstract »    Full Text »    PDF »
Proteolytic Antibodies against Factor VIII in Hemophilia A.
B. D. Stollar (2002)
N. Engl. J. Med. 346, 702-703
   Full Text »    PDF »
Energetic analysis of binding of progesterone and 5{beta}-androstane-3,17-dione to anti-progesterone antibody DB3 using molecular dynamics and free energy calculations.
M. Perakyla and N. Nordman (2001)
Protein Eng. Des. Sel. 14, 753-758
   Abstract »    Full Text »    PDF »
Blue-Fluorescent Antibodies.
A. Simeonov, M. Matsushita, E. A. Juban, E. H. Z. Thompson, T. Z. Hoffman, A. E. Beuscher IV, M. J. Taylor, P. Wirsching, W. Rettig, J. K. McCusker, et al. (2000)
Science 290, 307-313
   Abstract »    Full Text »
Structural evidence for a programmed general base in the active site of a catalytic antibody.
B. Golinelli-Pimpaneau, O. Goncalves, T. Dintinger, D. Blanchard, M. Knossow, and C. Tellier (2000)
PNAS 97, 9892-9895
   Abstract »    Full Text »    PDF »
Evolution of Shape Complementarity and Catalytic Efficiency from a Primordial Antibody Template.
J. Xu, Q. Deng, J. Chen, K. N. Houk, J. Bartek, D. Hilvert, and I. A. Wilson (1999)
Science 286, 2345-2348
   Abstract »    Full Text »
Multiple event activation of a generic prodrug trigger by antibody catalysis.
D. Shabat, C. Rader, B. List, R. A. Lerner, and C. F. Barbas III (1999)
PNAS 96, 6925-6930
   Abstract »    Full Text »    PDF »
Bringing biological solutions to chemical problems.
P. G. Schultz (1998)
PNAS 95, 14590-14591
   Full Text »    PDF »
A method for directed evolution and functional cloning of enzymes.
H. Pedersen, S. Holder, D. P. Sutherlin, U. Schwitter, D. S. King, and P. G. Schultz (1998)
PNAS 95, 10523-10528
   Abstract »    Full Text »    PDF »
A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
P. Wentworth Jr., Y. Liu, A. D. Wentworth, P. Fan, M. J. Foley, and K. D. Janda (1998)
PNAS 95, 5971-5975
   Abstract »    Full Text »    PDF »
Immunological Origins of Binding and Catalysis in a Diels-Alderase Antibody.
F. E. Romesberg, B. Spiller, P. G. Schultz, and R. C. Stevens (1998)
Science 279, 1929-1933
   Abstract »    Full Text »
An Antibody exo Diels-Alderase Inhibitor Complex at 1.95 Angstrom Resolution.
A. Heine, E. A. Stura, J. T. Yli-Kauhaluoma, C. Gao, Q. Deng, B. R. Beno, K. N. Houk, K. D. Janda, and I. A. Wilson (1998)
Science 279, 1934-1940
   Abstract »    Full Text »
A glycosidase antibody elicited against a chair-like transition state analog by in vitro immunization.
J. Yu, S. Y. Choi, K.-D. Moon, H.-H. Chung, H. J. Youn, S. Jeong, H. Park, and P. G. Schultz (1998)
PNAS 95, 2880-2884
   Abstract »    Full Text »    PDF »
Immune Versus Natural Selection: Antibody Aldolases with Enzymic Rates But Broader Scope.
C. F. Barbas III, A. Heine, G. Zhong, T. Hoffmann, S. Gramatikova, R. Björnestedt, B. List, J. Anderson, E. A. Stura, I. A. Wilson, et al. (1997)
Science 278, 2085-2092
   Abstract »    Full Text »
Pharmacogenetics in Biological Perspective.
W. Kalow (1997)
Pharmacol. Rev. 49, 369-380
   Abstract »    Full Text »    PDF »
Evolution of the folding ability of proteins through functional selection.
S. Saito, M. Sasai, and T. Yomo (1997)
PNAS 94, 11324-11328
   Abstract »    Full Text »    PDF »
Phage display of a catalytic antibody to optimize affinity for transition-state analog binding.
M. Baca, T. S. Scanlan, R. C. Stephenson, and J. A. Wells (1997)
PNAS 94, 10063-10068
   Abstract »    Full Text »    PDF »
Analysis of highly disfavored processes through pathway-specific correlated fluorescence.
J. J. L. Clair (1997)
PNAS 94, 1623-1628
   Abstract »    Full Text »    PDF »
Chicken Avidin Exhibits Pseudo-catalytic Properties. BIOCHEMICAL, STRUCTURAL, AND ELECTROSTATIC CONSEQUENCES.
T. Huberman, Y. Eisenberg-Domovich, G. Gitlin, T. Kulik, E. A. Bayer, M. Wilchek, and O. Livnah (2001)
J. Biol. Chem. 276, 32031-32039
   Abstract »    Full Text »    PDF »
Reaction Mechanism of Chalcone Isomerase. pH DEPENDENCE, DIFFUSION CONTROL, AND PRODUCT BINDING DIFFERENCES.
J. M. Jez and J. P. Noel (2002)
J. Biol. Chem. 277, 1361-1369
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)